Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Buprenorphine on Withdrawal Symptoms, Depression and Suicidal Thoughts
IRCT2016071325160N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by Shiraz University of Medical Sciences. Started Jun 2016; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT2016071325160N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016071325160N4.